Replacement therapy of hypothyroidism with T4 plus T3 does not improve mood and cognitive performance compared to the standard T4 monotherapy. There is even a higher risk of signs of subclinical hyperthyroidism associated with impaired well-being of the patients, which is clearly caused by significant fluctuations in the steady-state fT3 serum concentrations.

Objective Intolerance of uncertainty (IU) is a trait variable that captures an individual's lack of tolerance for unknown outcomes and events. Positive correlations between IU and mental health symptoms have been observed in various populations, while social variables (social support and decreased loneliness) seem to serve as protective factors against psychological distress among individuals with cancer. The present study examined the moderation effect of social support and loneliness in the relationship between IU and mental health symptoms among women diagnosed with ovarian cancer. Methods This study was a cross‐sectional design involving 131 women diagnosed with ovarian cancer recruited through social media and other online sources. Participants completed questionnaires that assessed their IU (prospective and inhibitory), anxiety symptoms, depressive symptoms, social support, and loneliness. Moderated regression analyses were applied to test the hypothesis that low social support and high loneliness would exacerbate the relationship between IU and symptoms of anxiety and depression. Results The hypothesized moderation effects (social support × IU, loneliness × IU) were not supported in the anxiety and depressive symptoms models. Post hoc linear regression analyses indicated that IU and loneliness were predictive of depressive and anxiety symptoms. Loneliness was the strongest predictor in both the anxiety and depressive symptoms models, followed by IU. Conclusions The findings indicate that loneliness and IU—particularly inhibitory IU—are important considerations in understanding mental health symptoms among women diagnosed with ovarian cancer. Addressing both loneliness and IU may be an important avenue in clinical settings.

No abstract

Panic disorder with agoraphobia (PD/AG) is one of the most costly and disabling anxiety disorders with a large range of secondary mental health problems. According to numerous clinical trials, cognitive-behavioural therapy (CBT) represents the most effective psychotherapeutic intervention for PD/AG. Little is known about the exact mechanisms of CBT and their neurobiological effects on the fear network. Within the PANIC-NET a unique, large multilevel and multicenter research project was implemented. By carrying out a randomized controlled clinical trial, different CBT components (exposure vs. cognitive techniques) were investigated in 360 patients in order to identify the core active ingredients of CBT. Furthermore, experimental add-on therapy with D-Cycloserine was tested. In an integrated approach, fear-circuit mechanisms were investigated employing psychophysiological techniques, functional neuro-imaging using 3T-fMRI and molecular genetic approaches.

No abstract